ABSTRACT
Fatigue is a major problem in multiple sclerosis (MS). It is experienced by 80-97% of individuals with MS,1-6 leads to early retirement7 and interferes with multiple aspects of general well-being.2,8-10 While neurologists and MS specialists recognize fatigue as clinically important,11 it remains poorly understood. This chapter reviews fatigue assessment, treatment and related issues of pathogenesis.
